| Kathleen M Thomas, DO | |
|
9669 E 146th St, Suite 250a, Noblesville, IN 46060-5004 | |
| (317) 621-1340 | |
| (317) 621-1341 |
| Full Name | Kathleen M Thomas |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 23 Years |
| Location | 9669 E 146th St, Noblesville, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467474031 | NPI | - | NPPES |
| 000000658832 | Other | IN | ANTHEM |
| P01009931 | Other | IN | MEDICARE RR |
| 000000575025 | Other | IN | ANTHEM |
| 200469250 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 02002532A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Riverview Health | Noblesville, IN | Hospital |
| Community Howard Regional Health Inc. | Kokomo, IN | Hospital |
| Community Hospital North | Indianapolis, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rheumatology Associates, P.c. | 2668550955 | 8 |
News Archive
Chronic obstructive pulmonary disease or COPD is associated with higher rates of many cancers, including lung, esophagus, colon, bladder and breast cancer.
Novartis today announced data from the Phase III COMBI-d study showing a significant survival benefit for patients with BRAF V600E/K mutation-positive metastatic melanoma when treated with the combination of Tafinlar (dabrafenib) and Mekinist (trametinib) compared to Tafinlar monotherapy alone.
Sinexus has changed its name to Intersect ENT. Intersect's initial focus is a bioabsorbable drug eluting stent to treat patients with chronic sinusitis, a debilitating condition that affects 37 million people each year and is more prevalent than heart disease or asthma.
Researchers at the University of Cincinnati have found in a retrospective study that African-American men are less likely to use a more targeted biopsy option for prostate cancer, despite an increased incidence in this group of patients.
› Verified 6 days ago
| Entity Name | Rheumatology Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154452696 PECOS PAC ID: 2668550955 Enrollment ID: O20090528000272 |
News Archive
Chronic obstructive pulmonary disease or COPD is associated with higher rates of many cancers, including lung, esophagus, colon, bladder and breast cancer.
Novartis today announced data from the Phase III COMBI-d study showing a significant survival benefit for patients with BRAF V600E/K mutation-positive metastatic melanoma when treated with the combination of Tafinlar (dabrafenib) and Mekinist (trametinib) compared to Tafinlar monotherapy alone.
Sinexus has changed its name to Intersect ENT. Intersect's initial focus is a bioabsorbable drug eluting stent to treat patients with chronic sinusitis, a debilitating condition that affects 37 million people each year and is more prevalent than heart disease or asthma.
Researchers at the University of Cincinnati have found in a retrospective study that African-American men are less likely to use a more targeted biopsy option for prostate cancer, despite an increased incidence in this group of patients.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathleen M Thomas, DO 6626 E 75th St, 500, Indianapolis, IN 46250-2805 Ph: () - | Kathleen M Thomas, DO 9669 E 146th St, Suite 250a, Noblesville, IN 46060-5004 Ph: (317) 621-1340 |
News Archive
Chronic obstructive pulmonary disease or COPD is associated with higher rates of many cancers, including lung, esophagus, colon, bladder and breast cancer.
Novartis today announced data from the Phase III COMBI-d study showing a significant survival benefit for patients with BRAF V600E/K mutation-positive metastatic melanoma when treated with the combination of Tafinlar (dabrafenib) and Mekinist (trametinib) compared to Tafinlar monotherapy alone.
Sinexus has changed its name to Intersect ENT. Intersect's initial focus is a bioabsorbable drug eluting stent to treat patients with chronic sinusitis, a debilitating condition that affects 37 million people each year and is more prevalent than heart disease or asthma.
Researchers at the University of Cincinnati have found in a retrospective study that African-American men are less likely to use a more targeted biopsy option for prostate cancer, despite an increased incidence in this group of patients.
› Verified 6 days ago
Dr. Sarah Catherine Perryman, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5540 Pebble Village Ln Ste 200, Noblesville, IN 46062 Phone: 317-900-4060 Fax: 317-900-4698 | |
Lori A Brame, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 395 Westfield Rd, Suite D, Noblesville, IN 46060 Phone: 317-776-3520 Fax: 317-776-3522 | |
Raj N Nagaraj, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 395 Westfield Rd Ste D, Noblesville, IN 46060 Phone: 317-776-3520 Fax: 317-776-3522 | |
Bruce F Schilt, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 17525 River Rd, Noblesville, IN 46062 Phone: 317-773-7711 Fax: 317-776-6561 | |
Dr. Navneet Lather, MD, MPH Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 17525 River Rd, Noblesville, IN 46062 Phone: 317-773-7711 | |
Agnes J Schrader, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 165 Sheridan Rd, Noblesville, IN 46060 Phone: 317-773-0363 Fax: 317-770-8910 | |
Joseph M Pyles, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 17525 River Rd, Noblesville, IN 46062 Phone: 317-773-7711 |